Literature DB >> 16164631

Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells.

Marieke S J Schepers1, Eddy S van Ballegooijen, Chris H Bangma, Carl F Verkoelen.   

Abstract

BACKGROUND: The interaction between renal tubular cells and crystals generated in the tubular fluid could play an initiating role in the pathophysiology of calcium oxalate nephrolithiasis. Crystals are expected to form in the renal collecting ducts, but not in the proximal tubule. In the present investigation, we studied the damaging effect of calcium oxalate crystals on renal proximal and collecting tubule cells in culture.
METHODS: Studies were performed with the renal proximal tubular cell lines, porcine proximal tubular cells (LLC-PK(1)) and Madin-Darby canine kidney II (MDCK-II) and the renal collecting duct cell lines, RCCD(1) and MDCK-I. Confluent monolayers cultured on permeable growth substrates in a two-compartment culture system were apically exposed to calcium oxalate monohydrate crystals, after which several cellular responses were studied, including monolayer morphology (confocal microscopy), transepithelial electrical resistances (TER), prostaglandin E(2) (PGE(2)) secretion, DNA synthesis ([(3)H]-thymidine), total cell numbers, reactive oxygen species [hydrogen peroxide (H(2)O(2))] generation, apoptotic (annexin V and DNA fragmentation), and necrotic (propidium iodide influx) cell death.
RESULTS: Crystals were rapidly taken up by proximal tubular cells and induced a biphasic response. Within 24 hours approximately half of the cell-associated crystals were released back into the apical fluid (early response). Over the next 2 weeks half of the remaining internalized crystals were eliminated (late response). The early response was characterized by morphologic disorder, increased synthesis of PGE(2), H(2)O(2), and DNA and the release of crystal-containing cells from the monolayers. These released cells appeared to be necrotic, but not apoptotic cells. Scrape-injured monolayers generated even higher levels of H(2)O(2) than those generated in response to crystals. During the late response, crystals were gradually removed from the monolayers without inflammation-mediated cell death. Crystals did not bind to, were not taken up by, and did not cause marked responses in collecting tubule cells.
CONCLUSION: This study shows that calcium oxalate crystals cause acute inflammation-mediated necrotic cell death in renal proximal tubular cells, but not in collecting tubule cells. The crystal-induced generation of reactive oxygen species by renal tubular cells is a general response to tissue damage and the increased levels of DNA synthesis seem to reflect regeneration rather than growth stimulation. As long as the renal collecting ducts are not obstructed with crystals, these results do not support an important role for crystal-induced tissue injury in the pathophysiology of calcium oxalate nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164631     DOI: 10.1111/j.1523-1755.2005.00566.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  37 in total

Review 1.  The tubular epithelium in the initiation and course of intratubular nephrocalcinosis.

Authors:  Benjamin A Vervaet; Anja Verhulst; Marc E De Broe; Patrick C D'Haese
Journal:  Urol Res       Date:  2010-08-02

2.  Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria.

Authors:  Ellen R Brooks; Bernd Hoppe; Dawn S Milliner; Eduardo Salido; John Rim; Leah M Krevitt; Julie B Olson; Heather E Price; Gulsah Vural; Craig B Langman
Journal:  Am J Nephrol       Date:  2016-05-03       Impact factor: 3.754

Review 3.  Primary hyperoxalurias: diagnosis and treatment.

Authors:  Efrat Ben-Shalom; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2014-12-18       Impact factor: 3.714

4.  l-ornithine activates Ca2+ signaling to exert its protective function on human proximal tubular cells.

Authors:  Samuel Shin; Farai C Gombedza; Bidhan C Bandyopadhyay
Journal:  Cell Signal       Date:  2019-11-23       Impact factor: 4.315

5.  Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes.

Authors:  Petter Bjornstad; David M Maahs; Carlos A Roncal; Janet K Snell-Bergeon; Viral N Shah; Tamara Milagres; Samuel L Ellis; Matthew Hatch; Linh T Chung; Marian J Rewers; Satish Garg; David Z Cherney; Laura Pyle; Kristen J Nadeau; Richard J Johnson
Journal:  Diabetes Obes Metab       Date:  2018-03-24       Impact factor: 6.577

6.  Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion.

Authors:  Shrikant R Mulay; Onkar P Kulkarni; Khader V Rupanagudi; Adriana Migliorini; Murthy N Darisipudi; Akosua Vilaysane; Daniel Muruve; Yan Shi; Fay Munro; Helen Liapis; Hans-Joachim Anders
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

7.  Bacterial LPS-mediated acute inflammation-induced spermatogenic failure in rats: role of stress response proteins and mitochondrial dysfunction.

Authors:  Mallikarjuna Reddy Metukuri; Chandra Mohan T Reddy; P R K Reddy; Pallu Reddanna
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

Review 8.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

9.  Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.

Authors:  Fang Zhao; Eric J Bergstralh; Ramila A Mehta; Lisa E Vaughan; Julie B Olson; Barbara M Seide; Alicia M Meek; Andrea G Cogal; John C Lieske; Dawn S Milliner
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-10       Impact factor: 8.237

10.  Engineering of polarized tubular structures in a microfluidic device to study calcium phosphate stone formation.

Authors:  Zengjiang Wei; Prince K Amponsah; Mariyam Al-Shatti; Zhihong Nie; Bidhan C Bandyopadhyay
Journal:  Lab Chip       Date:  2012-10-21       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.